Charles Albright

2019

In 2019, Charles Albright earned a total compensation of $2M as Executive Vice President and Chief Scientific Officer at Editas Medicine, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$296,954
Option Awards$701,454
Salary$427,774
Stock Awards$562,078
Other$8,063
Total$1,996,323

Albright received $701.5K in option awards, accounting for 35% of the total pay in 2019.

Albright also received $297K in non-equity incentive plan, $427.8K in salary, $562.1K in stock awards and $8.1K in other compensation.

Rankings

In 2019, Charles Albright's compensation ranked 5,929th out of 13,971 executives tracked by ExecPay. In other words, Albright earned more than 57.6% of executives.

ClassificationRankingPercentile
All
5,929
out of 13,971
58th
Division
Manufacturing
2,218
out of 5,701
61st
Major group
Chemicals And Allied Products
803
out of 2,200
64th
Industry group
Drugs
678
out of 1,886
64th
Industry
Biological Products, Except Diagnostic Substances
161
out of 389
59th
Source: SEC filing on April 28, 2020.

Albright's colleagues

We found six more compensation records of executives who worked with Charles Albright at Editas Medicine in 2019.

2019

Cynthia Collins

Editas Medicine

Chief Executive Officer

2019

Judith Abrams

Editas Medicine

Chief Medical Officer

2019

Vic Myer

Editas Medicine

Chief Technology Officer

2019

Eric Ek

Editas Medicine

Chief Financial Officer

2019

Katrine Bosley

Editas Medicine

Chief Executive Officer

2019

Andrew Hack

Editas Medicine

Chief Financial Officer

News

You may also like